BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7548701)

  • 1. Sequential monitoring of survival data with the Wilcoxon statistic.
    Lan KK; Rosenberger WF; Lachin JM
    Biometrics; 1995 Sep; 51(3):1175-83. PubMed ID: 7548701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A group sequential test for survival trials: an alternative to rank-based procedures.
    Li Z
    Biometrics; 1999 Mar; 55(1):277-83. PubMed ID: 11318168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A useful design utilizing the information fraction in a group sequential clinical trial with censored survival data.
    Hsu CY; Chen CH; Hsu KN; Lu YH
    Biometrics; 2019 Mar; 75(1):133-143. PubMed ID: 30004574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of group sequential logrank tests in a maximum duration trial.
    Lan KK; Lachin JM
    Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy.
    Martí-Carvajal AJ; Kwong JS
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009077. PubMed ID: 27388039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric test of stochastic ordering for multiple longitudinal measures.
    Rosenberger WF; Lachin JM; Bain RP
    J Biopharm Stat; 1995 Nov; 5(3):235-43. PubMed ID: 8580926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes.
    Sugimoto T; Hamasaki T; Evans SR; Halabi S
    Lifetime Data Anal; 2020 Apr; 26(2):266-291. PubMed ID: 30980317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing complex group sequential survival trials.
    Lakatos E
    Stat Med; 2002 Jul; 21(14):1969-89. PubMed ID: 12111882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo effect-adjusted assessment of quality of life in placebo-controlled clinical trials.
    Eickhoff JC
    Stat Med; 2008 Apr; 27(9):1387-402. PubMed ID: 18219702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential monitoring of randomization tests: stratified randomization.
    Zhang Y; Rosenberger WF; Smythe RT
    Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of logrank tests and group sequential methods at fixed calendar times.
    DeMets DL; Gail MH
    Biometrics; 1985 Dec; 41(4):1039-44. PubMed ID: 4096915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic heart failure and the quality of life.
    Alhaddad IA
    N Engl J Med; 1999 May; 340(19):1511-2. PubMed ID: 10328721
    [No Abstract]   [Full Text] [Related]  

  • 14. Worst-rank score analysis with informatively missing observations in clinical trials.
    Lachin JM
    Control Clin Trials; 1999 Oct; 20(5):408-22. PubMed ID: 10503801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exact permutational tests for group sequential clinical trials.
    Mehta CR; Patel N; Senchaudhuri P; Tsiatis A
    Biometrics; 1994 Dec; 50(4):1042-53. PubMed ID: 7786986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic heart failure and the quality of life.
    Pritzker MR
    N Engl J Med; 1999 May; 340(19):1511; author reply 1512. PubMed ID: 10328720
    [No Abstract]   [Full Text] [Related]  

  • 18. Visualization and dynamics of multidimensional health-related quality-of-life-adjusted overall survival: a new analytic approach.
    Andrei AC; Grady KL
    Qual Life Res; 2014 Jun; 23(5):1411-9. PubMed ID: 24395525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible implementations of group sequential stopping rules using constrained boundaries.
    Burington BE; Emerson SS
    Biometrics; 2003 Dec; 59(4):770-7. PubMed ID: 14969454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design considerations in crossover trials with a single interim analysis and serial patient entry.
    Cook RJ; Willan AR
    Biometrics; 1996 Jun; 52(2):732-9. PubMed ID: 8672709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.